Angel Investors Network

    Tag

    Pricing At The Bottom Of Its Range

    A dim biotech laboratory bench with racks of sample tubes and a pipette in warm gold light, with a researcher in a lab coat seen from behind in the background.
    Market Analysis

    TRex Bio Prices $116.7M IPO at Bottom of Range

    TL;DR: TRex Bio, a clinical stage biotech targeting autoimmune and inflammatory disease, raised $116.7 million in a U.S. IPO , selling about 8.3 million shares at $14 each. The company had marketed t…

    Jeff Barnes, MBA··5 min read